MilestonePurity seller sentenced to 21 months for selling semaglutide and tirzepatide imported from China
Short answer · as of 2026-10-06
DOCUMENTED. A U.S. Attorney’s Office release dated July 23, 2026 says Brandon Piper of Gobles, Michigan was sentenced to 21 months in prison for conspiracy to introduce misbranded drugs with intent to defraud and mislead the FDA and consumers, in a case involving semaglutide and tirzepatide imported from China.
Attribution: Compiled from the U.S. Attorney’s Office, Western District of Michigan, release of July 23, 2026, read directly, with context from WMUK (Feb. 25, 2026). The release does not state a plea date, restitution or forfeiture.
What happened
The U.S. Attorney’s Office for the Western District of Michigan announced on July 23, 2026 that Brandon Piper, 35, of Gobles, Michigan, was sentenced to 21 months in prison for conspiracy to introduce misbranded drugs into the market with intent to defraud and mislead the FDA and consumers.
DOJ says the drugs were unapproved prescription drugs imported from China, including semaglutide and tirzepatide, sold through a Canadian website and MilestonePurity.com. Both sites said the products were for research purposes only.
DOJ says the defendants knew customers would use the drugs personally, that no prescription was required, that the drugs lacked the FDA boxed warning about thyroid C-cell tumors, and that a “Product of the USA” label was false.
The case was investigated by FDA’s Office of Criminal Investigations. The release names Mayze Nichols as scheduled to be sentenced on related charges on Sept. 15, 2026.
WMUK reported on Feb. 25, 2026 that a charging document had been filed in the case.
What we can verify
- The sentence, charge, products, websites and investigating agency are stated in the release itself.
- The release records both that the sites said “for research purposes only” and that DOJ says the defendants knew customers would use the drugs personally.
What remains unknown
- The date and terms of Piper’s plea, and any restitution, forfeiture or supervised release: not in the release.
- The outcome for Nichols and whether other co-conspirators were charged.
- Whether MilestonePurity.com is operating now: we did not check.
Timeline
| Date / time | Event |
|---|---|
| 2026-02-25 | WMUK reports a charging document filed in federal court in Western Michigan. |
| 2026-07-23 | Piper is sentenced to 21 months; DOJ publishes its release. |
| 2026-09-15 | Date the release gives for Nichols’s scheduled sentencing; no outcome located. |
Participating agencies
| Agency | Reported role or presence |
|---|---|
| FDA Office of Criminal Investigations | Investigating agency, per the release. |
| U.S. Attorney’s Office, W.D. Michigan | Prosecuting office; Assistant U.S. Attorney Stephanie M. Carowan. |
Receipts
- U.S. Attorney’s Office, W.D. Michigan: Gobles man sentenced for selling Chinese drugs without FDA approval (July 23, 2026)
- WMUK: A Gobles man faces a felony charge for allegedly selling mislabeled and unapproved drugs (Feb. 25, 2026)
Company response
No company response located as of the publish date.
Why people care
The sites called the products research-only, and DOJ says the sellers knew buyers would use them on themselves. It is a prison sentence involving the same GLP-1 ingredients that appear in FDA’s warning letters.
Common questions
Was anyone sentenced over MilestonePurity?
Per the U.S. Attorney’s Office for the Western District of Michigan, Brandon Piper of Gobles, Michigan was sentenced on July 23, 2026 to 21 months for conspiracy to introduce misbranded drugs with intent to defraud and mislead, in a case involving semaglutide and tirzepatide sold through MilestonePurity.com. The release does not say he owned the site.
Terms explained
- Does “research use only” on a label make peptides legal to sell?
- What does “misbranded” mean in an FDA letter?
- What FDA warning letters say about compounded GLP-1s
Corrections and update log
No corrections or updates. Request a correction.
Related vendor records
Related stories
DOCUMENTED, ALLEGATION ONLY. A U.S. Attorney’s Office release dated April 1, 2026 says Justin Bradley Watkins, a Utah-licensed osteopathic physician, was indicted on charges involving misbranded drugs from China. An indictment is an allegation, and the release says defendants are presumed innocent until proven guilty.
DOCUMENTED. U.S. Attorney’s Office releases describe three earlier prosecutions tied to peptide-type injectables: Tailor Made Compounding and Jeremy Delk (sentenced Feb. 24, 2021), Precision Peptides owner Gavin Burns Smith (May 9, 2016) and Adam F. Higdon (Oct. 15, 2013). None of the sentences in those releases was a federal prison term.
REPORTED. Local outlets say the U.S. Postal Inspection Service led a Sept. 23 search of Apex Waste Management in North Sioux City, SD, whose officers are tied in state records to Apex Peptides; none of those outlets reports FDA involvement or charges.